Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 27, 2015 - Issue 2
607
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence, incidence, mortality and co-morbidities amongst human immunodeficiency virus (HIV) patients in Stockholm County, Sweden – The Greater Stockholm HIV Cohort Study

, , &
Pages 142-149 | Received 24 Mar 2014, Accepted 30 Aug 2014, Published online: 03 Oct 2014

References

  • Baral, S. D., Poteat, T., Stromdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. The Lancet Infectious Diseases, 13, 214–222. doi:10.1016/S1473-3099(12)70315-8
  • Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., … Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 220, 868–871. doi:10.1126/science.6189183.
  • Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., … Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus–infected adults in the United States. Archives of General Psychiatry, 58, 721–728. doi:10.1001/archpsyc.58.8.721.
  • Bontell, I., Haggblom, A., Bratt, G., Albert, J., & Sonnerborg, A. (2013). Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997–2011. PloS One, 8, e59337. doi:10.1371/journal.pone.0059337
  • Boyle, B. A., Jayaweera, D., Witt, M. D., Grimm, K., Maa, J. F., & Seekins, D. W. (2008). Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression. HIV Clinical Trials, 9, 164–176. doi:10.1310/hct0903-164
  • Burstrom, B. (2009). Will Swedish healthcare reforms affect equity? BMJ, 339, b4566. doi:10.1136/bmj.b4566
  • Calza, L., Manfredi, R., & Chiodo, F. (2004). Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. The Journal of Antimicrobial Chemotherapy, 53(1), 10–14. doi:10.1093/jac/dkh013
  • Carlsson, A. C., Wandell, P., Osby, U., Zarrinkoub, R., Wettermark, B., & Ljunggren, G. (2013). High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden – a challenge for public health. BMC Public Health, 13, 670. doi:10.1186/1471-2458-13-670
  • Carlsson, A. C., Wandell, P. E., Halldin, M., de Faire, U., & Hellenius, M. L. (2009). Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women. Metabolic Syndrome and Related Disorders, 7, 231–241. doi:10.1089/met.2008.0078
  • Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998). A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS, 12(7), F51–F58. doi:10.1097/00002030-199807000-00003
  • Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999). Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study. The Lancet, 353, 2093–2099. doi:10.1016/S0140-6736(98)08468-2
  • Chokunonga, E., Borok, M. Z., Chirenje, Z. M., Nyakabau, A. M., & Parkin, D. M. (2013). Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010. International Journal of Cancer, 133, 721–729. doi:10.1002/ijc.28063
  • Delgado, J., Heath, K. V., Yip, B., Marion, S., Alfonso, V., Montaner, J. S., … Hogg, R. S. (2003). Highly active antiretroviral therapy: Physician experience and enhanced adherence to prescription refill. Antiviral Therapy, 8, 471–478
  • Dube, M. P., Johnson, D. L., Currier, J. S., & Leedom, J. M. (1997). Protease inhibitor-associated hyperglycaemia. The Lancet, 350, 713–714. doi:10.1016/S0140-6736(05)63513-1
  • Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., … Siliciano, R. F. (1999). Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nature Medicine, 5, 512–517. doi:10.1038/8394
  • Friis-Moller, N., Sabin, C. A., Weber, R., d'Arminio Monforte, A., El-Sadr, W. M., Reiss, P., … Lundgren, J. D. (2003). Combination antiretroviral therapy and the risk of myocardial infarction. The New England Journal of Medicine, 349, 1993–2003. doi:10.1056/NEJMoa030218
  • The global HIV and AIDS epidemic, 2001. (2001). MMWR. Morbidity and Mortality Weekly Report, 50, 434–439.
  • Gottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., & Saxon, A. (1981). Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. The New England Journal of Medicine, 305, 1425–1431. doi:10.1056/NEJM198112103052401
  • Hardy, H., Esch, L. D., & Morse, G. D. (2001). Glucose disorders associated with HIV and its drug therapy. The Annals of Pharmacotherapy, 35, 343–351. doi:10.1345/aph.10044
  • Hatzenbuehler, M. L., Phelan, J. C., & Link, B. G. (2013). Stigma as a fundamental cause of population health inequalities. American Journal of Public Health, 103, 813–821. doi:10.2105/AJPH.2012.301069
  • Hleyhel, M., Belot, A., Bouvier, A. M., Tattevin, P., Pacanowski, J., Genet, P., … Grabar, S. (2013). Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: Results from the FHDH-ANRS CO4 cohort. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 57, 1638–1647. doi:10.1093/cid/cit497
  • Hymes, K. B., Cheung, T., Greene, J. B., Prose, N. S., Marcus, A., Ballard, H., … Laubenstein, L. J. (1981). Kaposi's sarcoma in homosexual men – a report of eight cases. The Lancet, 2, 598–600 doi:10.1016/S0140-6736(81)92740-9
  • Jansson, J., Wilson, D. P., Carr, A., Petoumenos, K., & Boyd, M. A. (2012). Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV. AIDS, 27, 1245–1251. doi:10.1097/QAD.0b013e32835e163d
  • Josephson, F., Albert, J., Flamholc, L., Gisslen, M., Karlstrom, O., Moberg, L., … Sonnerborg, A. (2009). Treatment of HIV infection: Swedish recommendations 2009. Scandinavian Journal of Infectious Diseases, 41, 788–807. doi:10.3109/00365540903214322
  • Justman, J. E., Benning, L., Danoff, A., Minkoff, H., Levine, A., Greenblatt, R. M., … Anastos, K. (2003). Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women. Journal of Acquired ImmuneDeficiency Syndromes, 32, 298–302. doi:10.1097/00126334-200303010-00009
  • Landon, B. E., Wilson, I. B., McInnes, K., Landrum, M. B., Hirschhorn, L. R., Marsden, P. V., & Cleary, P. D. (2005). Physician specialization and the quality of care for human immunodeficiency virus infection. Archives of Internal Medicine, 165, 1133–1139. doi:10.1001/archinte.165.10.1133
  • Libby, A. M., Fish, D. N., Hosokawa, P. W., Linnebur, S. A., Metz, K. R., Nair, K. V., … Hirsch, J. D. (2013). Patient-level medication regimen complexity across populations with chronic disease. Clinical Therapeutics, 35, 385–398 e381. doi:10.1016/j.clinthera.2013.02.019
  • Loutfy, M. R., Logie, C. H., Zhang, Y., Blitz, S. L., Margolese, S. L., Tharao, W. E., … Raboud, J. M. (2012). Gender and ethnicity differences in HIV-related stigma experienced by people living with HIV in Ontario, Canada. PLoS One, 7, e48168. doi:10.1371/journal.pone.0048168
  • Lyketsos, C. G., Hanson, A., Fishman, M., McHugh, P. R., & Treisman, G. J. (1994). Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. International Journal of Psychiatry in Medicine, 24(2), 103–113. doi:10.2190/URTC-AQVJ-N9KG-0RL4
  • Masur, H., Michelis, M. A., Greene, J. B., Onorato, I., Stouwe, R. A., Holzman, R. S., … Cunningham-Rundles, S. (1981). An outbreak of community-acquired Pneumocystis carinii pneumonia: Initial manifestation of cellular immune dysfunction. The New England Journal of Medicine, 305, 1431–1438. doi:10.1056/NEJM198112103052402
  • Nakagawa, F., May, M., & Phillips, A. (2013). Life expectancy living with HIV: Recent estimates and future implications. Current Opinion in Infectious Diseases, 26, 17–25. doi:10.1097/QCO.0b013e32835ba6b1
  • Naver, L., Bohlin, A. B., Albert, J., Flamholc, L., Gisslen, M., Gyllensten, K., … Lindgren, S. (2008). Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2007. Scandinavian Journal of Infectious Diseases, 40, 451–461. doi:10.1080/00365540801894787
  • Nel, A., & Kagee, A. (2013). The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa. AIDS Care, 25, 948–955. doi:10.1080/09540121.2012.748867
  • Pantaleo, G., & Levy, Y. (2013). Vaccine and immunotherapeutic interventions. Current Opinion in HIV and AIDS, 8, 236–242. doi:10.1097/COH.0b013e32835fd5cd
  • Powell, K., Davis, J. L., Morris, A. M., Chi, A., Bensley, M. R., & Huang, L. (2009). Survival for patients with HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest, 135(1), 11–17. doi:10.1378/chest.08-0980
  • Seaberg, E. C., Munoz, A., Lu, M., Detels, R., Margolick, J. B., Riddler, S. A., … Phair, J. P. (2005). Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS, 19, 953–960. doi:10.1097/01.aids.0000171410.76607.f8
  • Sekaly, R. P. (2008). The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development? The Journal of Experimental Medicine, 205(1), 7–12. doi:10.1084/jem.20072681
  • Sherbourne, C. D., Hays, R. D., Fleishman, J. A., Vitiello, B., Magruder, K. M., Bing, E. G., … Shapiro, M. F. (2000). Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. The American Journal of Psychiatry, 157, 248–254. doi:10.1176/appi.ajp.157.2.248
  • Silverberg, M. J., & Abrams, D. I. (2009). Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? Current Opinion in HIV and AIDS, 4(1), 42–51. doi:10.1097/COH.0b013e32831a9875
  • Spies, G., Asmal, L., & Seedat, S. (2013). Cognitive-behavioural interventions for mood and anxiety disorders in HIV: A systematic review. Journal of Affective Disorders, 150, 171–180. doi:10.1016/j.jad.2013.04.018
  • Steel, Z., Marnane, C., Iranpour, C., Chey, T., Jackson, J. W., Patel, V., & Silove, D. (2014). The global prevalence of common mental disorders: A systematic review and meta-analysis 1980–2013. International Journal of Epidemiology, 43, 476–493. doi:10.1093/ije/dyu038
  • Wand, H., Calmy, A., Carey, D. L., Samaras, K., Carr, A., Law, M. G., … Emery, S. (2007). Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS, 21, 2445–2453. doi:10.1097/QAD.0b013e3282efad32
  • Wandell, P., Carlsson, A. C., Wettermark, B., Lord, G., Cars, T., & Ljunggren, G. (2013). Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011. Family Practice, 30, 506–513. doi:10.1093/fampra/cmt033
  • Wirehn, A. B., Karlsson, H. M., & Carstensen, J. M. (2007). Estimating disease prevalence using a population-based administrative healthcare database. Scandinavian Journal of Public Health, 35, 424–431. doi:10.1080/14034940701195230

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.